NOVISOF L Tablet

Introduction

NOVISOF L is a prescription medication that contains the active ingredients Ledipasvir and Sofosbuvir. It is commonly used for the treatment of chronic hepatitis C virus (HCV) infection in adults. Ledipasvir and Sofosbuvir are antiviral medications that work together to inhibit the replication of the hepatitis C virus in the body.

Uses

NOVISOF L is primarily prescribed for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is used in patients with specific genotypes of the hepatitis C virus, including genotype 1, 4, 5, or 6. This medication is typically used in combination with other antiviral drugs as part of a comprehensive treatment regimen.

Dosage and Administration

The dosage of NOVISOF L may vary depending on the specific needs of the patient and the severity of the hepatitis C infection. Follow the instructions provided by the healthcare professional or the prescribing information on the medication label.

NOVISOF L is usually taken orally once daily with or without food. Take the medication consistently at the same time each day to maintain a steady level of the drug in the body. The duration of treatment may vary depending on individual factors and the response to therapy.

It is important not to miss any doses of NOVISOF L. If a dose is missed, it should be taken as soon as possible. However, if it is close to the time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be resumed. It is not recommended to take a double dose to make up for a missed dose.

It is advisable to consult a healthcare professional for specific dosage instructions and any concerns regarding the administration of NOVISOF L.

Mechanism of Action

NOVISOF L contains two active ingredients: Ledipasvir and Sofosbuvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A protein, which is essential for viral replication. Sofosbuvir is a nucleotide analog inhibitor of the hepatitis C virus NS5B RNA-dependent RNA polymerase, which is also necessary for viral replication.

By inhibiting these key proteins, NOVISOF L helps to prevent the replication of the hepatitis C virus in the body. This can lead to a reduction in the viral load and an improvement in liver function in patients with chronic hepatitis C infection.

Side Effects

Common side effects may include fatigue, headache, nausea, diarrhea, and insomnia. These side effects are usually mild and temporary.

In some cases, NOVISOF L may cause more serious side effects, such as severe allergic reactions, liver problems, or bradycardia (slow heart rate). If any of these serious side effects occur, seek medical attention immediately.

Note that this is not an exhaustive list of side effects. Patients should consult their healthcare professional for a complete list of potential side effects and what to do if they occur.

Drug Interactions

NOVISOF L may interact with other medications, including prescription drugs, over-the-counter medications, and herbal supplements. These interactions can affect the effectiveness of the medication or increase the risk of side effects.

Inform the healthcare professional about all medications and supplements being taken before starting treatment with NOVISOF L. They can provide guidance on potential drug interactions and adjust the treatment plan if necessary.

Patients should avoid starting, stopping, or changing the dosage of any medications without consulting their healthcare professional while taking NOVISOF L.

Precautions

Before taking NOVISOF L. Inform the healthcare professional about any pre-existing medical conditions, including liver problems, kidney problems, or any other significant health issues. This medication may not be suitable for individuals with certain medical conditions or may require dose adjustments.

NOVISOF L should not be used during pregnancy or while breastfeeding, as it may harm the unborn baby or pass into breast milk. Discuss the potential risks and benefits with a healthcare professional in these situations.

Additionally, NOVISOF L may interact with certain medications, including those used to treat HIV or tuberculosis. Inform the healthcare professional about all medications being taken to avoid potential drug interactions.

Storage

NOVISOF L should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Unused or expired medication should be properly disposed of according to local regulations or guidelines.

Patient Tips

• Take NOVISOF L exactly as prescribed by the healthcare professional.
• Do not miss any doses and try to take the medication at the same time each day.
• If a dose is missed, take it as soon as possible. However, if it is close to the time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule.
• Inform the healthcare professional about all medications and supplements being taken to avoid potential drug interactions.
• Report any unusual or persistent side effects to the healthcare professional.
• Follow any additional instructions provided by the healthcare professional for a successful treatment outcome.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Harvoni 33.75 mg/150 mg coated granules in sachet (Health Professionals SmPC) Available at:
• Ledipasvir and sofosbuvir (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
• ledipasvir-sofosbuvir (RX) [Accessed 6 Jun. 2024] (online) Available at:
• Ledipasvir and Sofosbuvir (MedlinePlus) [Accessed 1 Jun. 2024] (online) Available at:
• Scott LJ. Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C. Drugs. 2018 Feb;78(2):245-256. doi: 10.1007/s40265-018-0864-z. [Accessed 14 Jun. 2024] Available at: